Dr Amanda Roxburgh is a National Health and Medical Research Council (NHMRC) Research Fellow with the Burnet Institute. She has 18 years experience in the alcohol and other drug (AOD) research sector. She has published over 40 scientific publications and given 60 national and international conference presentations. Her research has led to a greater understanding of the changing nature of opioid overdose mortality in Australia and the contribution of pharmaceutical opioids to these deaths. Her work has informed legislative change in Australia (e.g. rescheduling of codeine and regulatory changes in dispensing of Schedule 8 opioids), and she has led briefings to government (e.g. the Australian Government Department of Health, and the Pharmaceutical Board Advisory Committee) and written commissioned (by the Intergovernmental Committee on Drugs – IGCD and the NSW Parliament) reports which have directly informed Australia’s National Drug Strategy.
Her current research focuses on understanding the factors driving non-fatal and fatal overdose in the context of contemporary drug markets, with the aim of informing overdose policy responses and reducing drug-related harms.